Tuesday, June 14, 2022

Chimeric (ASX:CHM) hits new milestone: viral vector manufactured for clinical program

A viral vector is considered as the backbone of CAR T cell therapy production as it holds the instructions of genetic engineering.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...